BRIEF-Amgen Receives Positive Opinion Expanding Use Of Xgeva (Denosumab)
February 23, 2018 at 08:46 AM EST
* AMGEN RECEIVES POSITIVE OPINION EXPANDING USE OF XGEVA® (DENOSUMAB) TO COVER PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA IN EUROPE Source text for Eikon: Further company coverage:
